연속 혈당 모니터링 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global continuous blood glucose monitoring market size is expected to reach USD 60.39 Billion in 2034 from USD 16.73 Billion in 2025, growing at a CAGR of 15.33% during 2026-2034.This market is growing as demand increases for technologies that provide frequent glucose information without requiring users to rely exclusively on conventional intermittent testing. Continuous glucose monitoring systems use sensors and associated software to provide ongoing information about glucose patterns, helping users and healthcare professionals better understand changes over time. According to the International Diabetes Federation, diabetes continues to represent a substantial global health challenge, supporting the need for improved glucose-management tools. Expanding awareness of diabetes management and technological improvements in wearable monitoring are encouraging wider interest in continuous glucose monitoring solutions.

The continuous blood glucose monitoring market is being influenced by improvements in sensor accuracy, wearability, connectivity, and data interpretation. Modern systems can transmit glucose information to smartphones and other connected devices, enabling users to review trends and receive alerts. Integration with digital health platforms is also creating opportunities for remote monitoring and more personalized care. Manufacturers are working to make sensors smaller, easier to apply, and more convenient for extended use. Reimbursement policies, affordability, clinical acceptance, and access to healthcare remain important factors influencing adoption across different countries and patient populations.

Future prospects are supported by continued innovation in minimally invasive monitoring and connected healthcare. Integration with insulin-delivery systems and digital therapeutic platforms could further increase the usefulness of continuous glucose information. Advances in sensor longevity, accuracy, affordability, and automated data analysis may broaden adoption beyond current user groups. Emerging markets could provide significant opportunities as healthcare infrastructure and awareness improve. Manufacturers that combine reliable sensing technology with intuitive software, secure data management, and accessible pricing are likely to strengthen their market positions as glucose monitoring becomes increasingly connected and data-driven.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Component

• Sensors
• Transmitters
• Receivers

By End User

• Hospitals/Clinics
• Home/Personal

By Demography

• Adult
• Pediatric

COMPANIES PROFILED

• A. Menarini Diagnostics S.r.l., Abbott Laboratories, Afon Technology Ltd., AgaMatrix, Inc., Ascensia Diabetes Care Holdings AG, Bilinq Incorporated (Biolinq Incorporated), DexCom, Inc., F. Hoffmann-La Roche Ltd., GlucoRx Limited, Glucotrack, Inc., HAGAR hf., i-SENS, Inc., Integrity Applications Inc., Know Labs, Inc., LifeScan, Inc., Medtronic plc, Medtrum Technologies Inc., MicroTech Medical (Hangzhou) Co., Ltd., Nemaura Medical Inc., Senseonics Holdings, Inc., Sinocare Inc., Terumo Corporation, Ypsomed Holding AG, Zhejiang POCTech Co., Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Sensors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Transmitters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Receivers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals/Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Home/Personal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. By Demography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Component
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Component
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Component
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Component
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Component
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 A. Menarini Diagnostics S.r.l
  • 8.2.2 Abbott Laboratories
  • 8.2.3 Afon Technology Ltd
  • 8.2.4 AgaMatrixInc
  • 8.2.5 Ascensia Diabetes Care Holdings AG
  • 8.2.6 Bilinq Incorporated (Biolinq Incorporated)
  • 8.2.7 DexComInc
  • 8.2.8 F. Hoffmann-La Roche Ltd
  • 8.2.9 GlucoRx Limited
  • 8.2.10 GlucotrackInc
  • 8.2.11 HAGAR Hf
  • 8.2.12 I-SENSInc
  • 8.2.13 Integrity Applications Inc
  • 8.2.14 Know LabsInc
  • 8.2.15 LifeScanInc
  • 8.2.16 Medtronic Plc
  • 8.2.17 Medtrum Technologies Inc
  • 8.2.18 MicroTech Medical (Hangzhou) Co.Ltd
  • 8.2.19 Nemaura Medical Inc
  • 8.2.20 Senseonics HoldingsInc
  • 8.2.21 Sinocare Inc
  • 8.2.22 Terumo Corporation
  • 8.2.23 Ypsomed Holding AG
  • 8.2.24 Zhejiang POCTech Co.Ltd